You are on page 1of 36

Vaginal Bleeding in

Late Pregnancy
Published August 2010

1
Objectives

• Identify major causes of vaginal bleeding in


the second half of pregnancy
• Describe a systematic approach to identifying
the cause of bleeding
• Describe specific treatment options based on
diagnosis

2
Causes of Late Pregnancy Bleeding

• Placenta Previa
• Abruption
Life-Threatening
• Uterine scar disruption
• Ruptured vasa previa
• Cervical polyp
• Bloody show
• Cervicitis or cervical ectropion
• Vaginal trauma
• Cervical cancer

3
Management of Significant Bleeding

• Same initial steps regardless of etiology


• Assess vital signs, circulatory stability
• Secure intravenous access, administer fluids
• Targeted history and physical exam
 Gentle speculum exam is safe
 NO digital vaginal exam unless placental location
known

4
Management, continued
• Continuous electronic fetal monitoring and toco
• Ultrasound for placenta location, clot, fetal position
• Baseline lab tests
 Hematocrit
 Platelet count
 Fibrinogen level, fibrin degradation products, INR, PTT
 Blood type and antibody screen
• Prepare for possible emergent cesarean delivery

5
Placenta Previa

Low-Lying: Marginal: Complete:


2 to 3.5 cm from os Within 2 cm Covers os

6
Prevalence of Placenta Previa

• Common finding on second trimester


ultrasound
• Previa occurs in approximately four percent
of pregnancies at 20 to 25 weeks, only 0.4
percent at term
 If overlaps os by > 2.5 cm, then likely to persist
• No proven benefit to routine screening
ultrasound in late pregnancy

7
Risk Factors for Placenta Previa

• Chronic hypertension
• Multiparity
• Multiple gestation
• Increasing maternal age
• Previous cesarean delivery
• Previous uterine curettage
• Smoking

8
Morbidity with Placenta Previa

• Maternal hemorrhage
• Transfusion
• Cesarean delivery
• Placenta accreta, increta, or percreta
 Increased risk of invasive placenta in women
with previa + prior cesarean
 Evaluate with color flow Doppler US
• Prematurity

9
Placenta Previa with Increta

10
Clinical Presentation - Previa

• Painless bleeding
 Second or third trimester, or at term
 Often following intercourse
 May have preterm contractions

• Suspect previa with persistent


malpresentation
• Diagnosis confirmed with ultrasound
localization of placenta

11
Ultrasound – Placenta Previa

• When previa seen on transabdominal US,


transvaginal scan should be performed
 More accurate visalization of placental edge and
internal os
• Full bladder can create false appearance of
anterior previa
• Presenting part may overshadow posterior
previa

12
Ultrasound – Placenta Previa

13
Management – Placenta Previa
• With no active bleeding  Expectant management
 No intercourse or tampons in third trimester
 Avoid digital exams
• With bleeding  Initial assessment in hospital
 Overall status, circulatory stability
 Full dose Rhogam if Rh neg
 Consider maternal transfer if premature
 May need corticosteroids, tocolysis, amniocentesis

14
Further Management
• May discharge home if stable after 72 hours
of inpatient observation
• Reduces stay in hospital by average of 14
days
• No increase in
 Hemorrhage
 Need for transfusion
 Poor maternal or neonatal outcomes

15
Neonatal Morbidity from Placenta Previa

• Greatest morbidity and mortality related to


prematurity
• Tocolysis added 11 days to pregnancy, 320
grams to birth weight in one study
 Allows for administration of corticosteroids
 No increase in maternal or fetal complications
• Cervical cerclage decreased risk of birth before
34 weeks in meta-analysis

16
Delivery Decisions – Placenta Previa

• Low lying placenta or marginal previa, no bleeding 


Perform US at 36 weeks
 If placenta > 2 cm from internal os, expect vaginal delivery
 If 1 to 2 cm from os, may attempt vaginal delivery in setting
with immediate surgical backup
• Perform cesarean delivery for:
 complete previa
 fetal head not engaged, non-reassuring tracing, brisk or
persistent bleeding
• Regional anesthesia is safe, less blood loss

17
Placental Abruption

• Occurs in one percent of pregnancies


• Premature separation of placenta from
uterine wall
 Partial or complete
• Apparent increase in incidence
 Increased diagnosis (ultrasound) vs. increased
risk factors (hypertension)

18
Risk Factors for Abruption

• Hypertensive disorders of pregnancy


 Treating preeclampsia with MgSO4 decreases risk by 27
percent
• Trauma
 Blunt abdominal trauma or rapid deceleration without direct
trauma
• Tobacco, cocaine, stimulants
• Thrombophilias
• Chorioamnionitis
• Oligiohydramnios, PROM
• Abruption in previous pregnancy

19
Clinical Presentation - Abruption

• Pain = hallmark symptom


 Varies from mild cramping to severe pain
 Back pain – think posterior abruption
• Vaginal bleeding or bloody amniotic fluid
 Differentiate from exuberant bloody show
• Concealed bleeding in 20 to 63 percent of
cases
 Visible bleeding may not reflect amount of blood
loss

20
Evaluation - Abruption

• Check vital signs for circulatory instability


• Palpate maternal abdomen
 Location of tenderness
 Tetanic contractions
• Monitor FHR and contractions
 Continuous FECG, consider amniotomy and IUPC
• Ultrasound or fundal height and Leopold’s
 Estimated fetal weight, fetal lie
 Evaluate placenta

21
Diagnosis - Abruption
Abruption is a clinical diagnosis!

Ultrasound findings may


be supportive:
Retroplacental echolucency
Abnormal thickening of
placenta
“Torn” edge of placenta

22
Abruption severity

Mild: often identified at delivery with


retroplacental clot
Moderate to severe: Symptomatic, tender
abdomen
Severe with fetal demise:
- without coagulopathy (two thirds)
- with coagulopathy (one third)

23
Management - Severe Abruption

• Expeditious operative or vaginal delivery


 Decision-to-delivery interval > 20 min increases incidence of
fetal death or cerebral palsy
• Maintain maternal circulation
 Urine output > 30 cc/hr, hematocrit > 30 percent
• Prepare for neonatal resuscitation
• If fetal demise
 Vaginal delivery preferred, unless severe hemorrhage
 Check for coagulopathy

24
Coagulopathy with Abruption

• Occurs in one third of fetal demise


• Usually not seen if live fetus
• Etiologies: consumption, DIC
• Administer platelets, FFP
• Give Factor VIII if severe

25
Uterine Rupture

• Occult dehiscence vs. symptomatic rupture


• Rare in unscarred uterus
 < 0.1 percent overall incidence
 0.8 percent of women with uterine scar
• Previous cesarean incision most common
etiology

26
Risk Factors – Uterine Rupture
• Previous cesarean incision (most common)
• Other uterine surgery involving full thickness
myometrium
• Inappropriate oxytocin usage
• Uterine over-distention
• Abnormal placental attachment, difficult
removal
• Uterine or fetal anomaly
• Gestational trophoblastic neoplasia
• Adenomyosis

27
Morbidity with Uterine Rupture

• Maternal
 hemorrhage with anemia (most common)
 bladder rupture
 hysterectomy
 maternal death
• Fetal
 respiratory distress
 hypoxia
 acidemia
 neonatal death

28
Clinical Findings – Uterine Rupture

• Sudden deterioration of FHR pattern is most


frequent initial sign
• Vaginal bleeding
• Pain
• “Stair step” decrease or cessation of contractions
• Loss of station
• Palpable fetal parts through maternal abdomen
• Profound maternal tachycardia and hypotension

29
Management – Uterine Rupture

• Asymptomatic scar disruption


 Expectant management

• Symptomatic rupture
 Emergent cesarean delivery
 Outcome good if decision to incision to delivery
time under 18 minutes in one study

30
Vasa Previa
• Fetal vessels run in membranes between cervix and
presenting part
• Rarest cause of hemorrhage
• Rapid intervention essential for fetal survival

31
Vasa Previa – Associated Conditions

 In vitro fertilization
 Low-lying placenta or
previa in second or
third trimester
 Bilobed and
succenturiate lobe
placentas
 Velamentous
insertion of the cord
Bi-lobed placenta with
Velamentous Insertion

32
Vasa Previa – Clinical Presentation

• Potential for ante partum detection


 Palpate vessels during cervical examination
 Color-flow Doppler ultrasound
• Typically, first sign is bleeding with membrane
rupture
• Blood loss is fetal
 Fetal circulation = 250 ml total

33
Intrapartum Management –
Vasa Previa

• Tests for fetal hgb have limited usefulness


 Apt test insensitive
 Kleihauer-Betke or hgb electrophoresis slow
• Immediate cesarean delivery if fetal heart
rate non-reassuring
• Administer normal saline 10 to 20 cc/kg bolus
to newborn if in shock after delivery

34
Antepartum Diagnosis – Vasa Previa

• Critical for fetal survival as allows planned


cesarean delivery
 97 percent survival when detected antenatally
 44 percent survival without antenatal diagnosis
• If placenta previa on second trimester US 
 Perform follow-up US with color-flow Doppler to
rule out vasa previa
• If persistent vasa previa 
 Corticosteriods, delivery at 35 to 36 weeks

35
Summary
• Late pregnancy bleeding may herald diagnoses with
significant morbidity/ mortality
• Rapid clinical diagnosis is imperative
• Sterile speculum exam is safe, but avoid vaginal
exam until placental location is known!
• Ultrasound has a supportive role in determining the
cause of bleeding
• When antenatal US identifies placenta previa, color
flow Doppler study is recommended to evaluate for
placenta accreta and vasa previa

36

You might also like